
No Difference Between Latiglutenase and Placebo in Reducing Villous Atrophy or Improving Symptoms in Patients With Symptomatic Celiac Disease
Keywords: Pathology; Healing; Inflammation; Treatment; AE; adverse events; ANCOVA; analysis of covariance; CDSD; celiac disease symptom diary; DGP; deamidated gliadin peptide; GFD; gluten-free diet; GI; gastrointestinal; ICDSQ; Impact of Celiac Disease Symptoms Que